ACM
STJ

Azimuth Capital Management’s St Jude Medical STJ Stock Holding History

Azimuth Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,550
Closed -$204K – 285
2016
Q4 		$204K Sell
2,550
-200
-7% -$15.9K 0.02% 274
2016
Q3 		$219K Hold
2,750
– – 0.02% 267
2016
Q2 		$215K Sell
2,750
-900
-25% -$64.2K 0.02% 267
2016
Q1 		$201K Buy
3,650
+150
+4% +$8.17K 0.02% 260
2015
Q4 		$216K Hold
3,500
– – 0.02% 259
2015
Q3 		$221K Hold
3,500
– – 0.02% 263
2015
Q2 		$256K Hold
3,500
– – 0.02% 269
2015
Q1 		$229K Buy
3,500
+150
+4% +$9.97K 0.02% 280
2014
Q4 		$218K Hold
3,350
– – 0.02% 277
2014
Q3 		$201K Sell
3,350
-100
-3% -$6.53K 0.02% 275
2014
Q2 		$239K Buy
3,450
+350
+11% +$22.7K 0.03% 267
2014
Q1 		$203K Buy
+3,100
New +$202K 0.02% 266

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Azimuth Capital Management's STJ Position: Q1 2017 in Review

Azimuth Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,550 shares — an estimated $204K sold.

Azimuth Capital Management first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $256K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Azimuth Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Azimuth Capital Management sold 2,550 St Jude Medical shares in Q1 2017, an estimated $204K.
  • Azimuth Capital Management first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
  • Azimuth Capital Management's St Jude Medical position peaked at $256K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Azimuth Capital Management's 13F filing for Q1 2017, filed 12 May 2017.